Radioiodine ablation – current trends and controversies
Management for differentiated thyroid cancer (DTC) has seen significant changes over the last decade. The approach is dramatically shifting to personalised based rational decisions. This includes, but is not limited to, the extent of surgery, active surveillance in low risk very limited disease, radioiodine (RAI) ablation or no ablation after initial surgery, low iodine activity […]
Dr Fahim Ul Hassan
Guy's and St Thomas' NHS Foundation Trust